These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C, Guan X, Xue H, Wang P, Wang M, Gai X. Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760 [Abstract] [Full Text] [Related]
5. [Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine]. Cheng YH, Qi J, Xiong DS, Liu JW, Qi SL, Pan B, Yang CZ, Zhu HF. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):164-8. PubMed ID: 16733896 [Abstract] [Full Text] [Related]
7. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro. Li F, Fan J, Wu Z, Liu RY, Guo L, Dong Z, Wang Z. Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360 [Abstract] [Full Text] [Related]
8. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX, Yang XH. Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [Abstract] [Full Text] [Related]
12. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil. Ye W, Chang HL, Wang LS, Huang YW, Shu S, Dowd MK, Wan PJ, Sugimoto Y, Lin YC. Anticancer Res; 2007 May; 27(1A):107-16. PubMed ID: 17352222 [Abstract] [Full Text] [Related]
13. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells. Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X. Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007 [Abstract] [Full Text] [Related]
14. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells. Chen F, Wang T, Wang J, Wang ZQ, Qian M. Acta Pharmacol Sin; 2008 Apr; 29(4):458-64. PubMed ID: 18358092 [Abstract] [Full Text] [Related]
15. Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein. Pan Q, Lu Q, Zhang K, Hu X. Cancer Chemother Pharmacol; 2006 Jul; 58(1):99-106. PubMed ID: 16231181 [Abstract] [Full Text] [Related]
16. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K. Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [Abstract] [Full Text] [Related]
17. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells. Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A. Anticancer Res; 2004 May; 24(2B):865-71. PubMed ID: 15161039 [Abstract] [Full Text] [Related]
18. [Screening effective sequences of small interfering RNAs targeting MDR1 gene in human gastric cancer SGC7901/VCR cells]. Gao FL, Wang F, Wu JL, LE XP, Zhang QX. Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):178-82. PubMed ID: 16875600 [Abstract] [Full Text] [Related]
19. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Tang XQ, Bi H, Feng JQ, Cao JG. Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636 [Abstract] [Full Text] [Related]
20. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Gan HZ, Zhang GZ, Zhao JS, Zhang FC, Bu LS, Yang SJ, Piao SL, Du ZW, Gao S, Zheng DM. Chin Med J (Engl); 2005 Jun 05; 118(11):893-902. PubMed ID: 15978189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]